About us Contact Terms of Use Data Sources Publications FAQ

Pancreatic Cancer

Molecular Synopsis

Drugs and clinical candidates

16 drugs have received FDA approval for Pancreatic Cancer:

  • /LU
  • Erlotinib
  • Everolimus
  • FR258900

314 drugs have a clinical trial registered for Pancreatic Cancer.

2601 compounds have been tested in Pancreatic Cancer (1868 <= 500nM potency) .

Sources: cancer.gov , clinicaltrials.gov , ChEMBL .

Clinical trials
There are 1892 clinical trials for Pancreatic Cancer, 1241 of which have one or more drug interventions, 651 with no drug intervention.
Cell line models

There is 318 Cell Line Models for Pancreatic Cancer.

Source: COSMIC
Mapped terms

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Pancreatic Cancer:
  • Carcinoma, Pancreatic Ductal
  • Pancreatic Intraductal Neoplasms
  • Pancreatic Neoplasms
The following terms have been mapped from cancer.gov to Pancreatic Cancer:
  • Pancreatic cancer. It is used alone in patients whose disease is locally advanced or metastatic and who have been treated with fluorouracil
  • Pancreatic cancer that has metastasized. It is used with gemcitabine hydrochloride
  • Pancreatic cancer
  • Pancreatic cancer that is advanced and has gotten worse after treatment with gemcitabine hydrochloride
  • Gastroenteropancreatic neuroendocrine tumors. It is used in some adults whose tumors cannot be removed by surgery, are locally advanced, or have metastasized (spread to other parts of the body)